COVID-19 Vaccination Linked to Small Increase in Menstrual Cycle Length
Data from the Natural Cycles app was analyzed for an association between COVID-19 vaccination menstrual cycle changes.
Data from the Natural Cycles app was analyzed for an association between COVID-19 vaccination menstrual cycle changes.
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
The Moderna booster dose is authorized for individuals 18 years of age and older.
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommends the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine in individuals 12 to 15 years of age at least 5 months after completion of the primary series. The advisory panel’s recommendations follow a similar decision made by…
The study was conducted at laboratories established by the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center at Duke University Medical Center.
The FDA study shows that the neutralizing potency of the antibody combination was within the range of neutralizing titers found in an individual previously infected with COVID-19.
The application is supported by data from a randomized, placebo-controlled phase 3 trial which included 2228 participants 12 to 15 years of age enrolled in the United States.
Cases of TTS have been reported in both males and females.
Individuals in this age group should only receive this vaccine as their booster.
The independent study conducted by Dan Barouch, MD, PhD, et al of Beth Israel Deaconess Medical Center included a subset of participants from the COV2008 study.